3B BLACKBIO DX LTD. Share Price
3B BLACKBIO DX LTD. Share Price Today
As of 5 Jul 2026, 3B BLACKBIO DX LTD. share price is ₹1,173.50. The stock opened at ₹1,208.90, compared to its previous close of ₹1,205.80. During today's trading session, 3B BLACKBIO DX LTD. share price moved in the range of ₹1,168.10 to ₹1,221.40, with an average price of ₹1,194.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,085.00 and a high of ₹1,441.50. On the performance front, 3B BLACKBIO DX LTD. share price has declined by 9.65% over the last six months and is down 9.65% on a year-on-year basis.
3B BLACKBIO DX LTD. Returns Calculator
3B BLACKBIO DX LTD. Shareholder Returns
3B BLACKBIO DX LTD. Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,25,057.00 | 62.45 | 13.20 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 76.08 | 10.21 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.15 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.34 | 8.94 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| Global Health | 36,176.70 | 65.28 | 9.13 | 14.05% | 0.06 | 15.26% | 149.24 | 0.04% | 0.77 | 18.46 |
| KRISHNA INST OF MED SCI L | 35,097.80 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 54.33 | 11.04 | 20.13% | 0.07 | 25.56% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,755.40 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| Poly Medicure | 17,614.20 | 54.92 | 5.67 | 10.37% | 0.08 | 12.71% | 301.18 | 0.20% | 0.53 | 33.15 |
3B BLACKBIO DX LTD. Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹96.47 | ₹74.12 | ₹61.84 | ₹80.65 |
| Other Income | ₹15.08 | ₹12.53 | ₹7.23 | ₹6.90 |
| Total Revenue | ₹111.55 | ₹86.66 | ₹69.06 | ₹87.55 |
| Total Expenses | ₹47.55 | ₹42.33 | ₹33.75 | ₹44.33 |
| Profit Before Tax | ₹64.00 | ₹44.33 | ₹35.31 | ₹43.22 |
| Tax | ₹16.31 | ₹12.23 | ₹9.37 | ₹11.02 |
| Profit After Tax | ₹47.69 | ₹32.10 | ₹25.94 | ₹32.20 |
| EPS - Basic | ₹55.66 | ₹37.46 | ₹34.62 | ₹43.40 |
| EPS - Diluted | ₹55.66 | ₹37.46 | ₹34.62 | ₹43.40 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹64.00 | ₹44.33 | ₹35.31 | ₹43.22 |
| Income before WC changes | ₹59.13 | ₹39.38 | ₹36.37 | ₹44.00 |
| Change in Assets | -₹2.11 | -₹9.85 | -₹2.38 | ₹30.65 |
| Change in Liabilities | ₹1.12 | ₹8.27 | -₹2.14 | -₹26.77 |
| Change in WC | -₹0.99 | -₹1.59 | -₹4.52 | ₹3.89 |
| Cash flow from Operations | ₹43.36 | ₹26.95 | ₹22.90 | ₹37.33 |
| Cash flow from Investing | -₹33.85 | -₹20.32 | ₹12.11 | -₹28.44 |
| Cash flow from Financing | -₹3.22 | -₹3.63 | -₹5.01 | -₹15.07 |
| Total Cash Flow | ₹6.29 | ₹3.01 | ₹30.01 | -₹6.19 |
| Cash (Start of the year) | ₹62.15 | ₹59.21 | ₹28.89 | ₹35.08 |
| Cash (End of the year) | ₹68.83 | ₹62.15 | ₹59.21 | ₹28.89 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹163.53 | ₹124.71 | ₹99.82 | ₹110.55 |
| Current Assets | ₹132.19 | ₹123.40 | ₹114.24 | ₹81.54 |
| Total Assets | ₹295.72 | ₹248.10 | ₹214.06 | ₹192.09 |
| Current Liabilities | ₹18.59 | ₹17.53 | ₹14.18 | ₹16.90 |
| Net Current Asset | ₹113.60 | ₹105.86 | ₹100.05 | ₹64.64 |
| Non-Current Liabilities | ₹6.13 | ₹5.10 | ₹3.96 | ₹3.11 |
| Equity Capital | ₹271.00 | ₹225.47 | ₹195.91 | ₹172.08 |
| Total Equity & Liabilities | ₹295.72 | ₹248.10 | ₹214.06 | ₹192.09 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹90.53 | ₹70.72 | ₹59.34 | ₹15.52 |
| Other Income | ₹15.03 | ₹12.32 | ₹7.26 | ₹10.09 |
| Total Revenue | ₹105.56 | ₹83.04 | ₹66.60 | ₹25.62 |
| Total Expenses | ₹41.63 | ₹36.60 | ₹30.76 | ₹17.15 |
| Profit Before Tax | ₹63.93 | ₹46.44 | ₹35.84 | ₹8.46 |
| Tax | ₹16.37 | ₹12.23 | ₹9.42 | ₹0.46 |
| Profit After Tax | ₹47.56 | ₹34.21 | ₹26.42 | ₹8.01 |
| EPS - Basic | ₹55.51 | ₹39.93 | ₹30.85 | ₹10.69 |
| EPS - Diluted | ₹55.51 | ₹39.93 | ₹30.85 | ₹10.69 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹63.93 | ₹46.44 | ₹35.84 | ₹8.46 |
| Income before WC changes | ₹58.82 | ₹41.29 | ₹34.22 | ₹8.86 |
| Change in Assets | -₹0.70 | -₹6.38 | -₹1.93 | -₹1.34 |
| Change in Liabilities | ₹1.19 | ₹4.39 | -₹2.15 | ₹0.62 |
| Change in WC | ₹0.49 | -₹1.99 | -₹4.08 | -₹0.71 |
| Cash flow from Operations | ₹44.47 | ₹28.47 | ₹21.16 | ₹7.98 |
| Cash flow from Investing | -₹33.64 | -₹20.32 | -₹7.80 | -₹1.52 |
| Cash flow from Financing | -₹3.07 | -₹3.62 | -₹2.89 | -₹6.31 |
| Total Cash Flow | ₹7.76 | ₹4.53 | ₹10.46 | ₹0.14 |
| Cash (Start of the year) | ₹54.88 | ₹50.35 | ₹39.89 | ₹1.71 |
| Cash (End of the year) | ₹62.63 | ₹54.88 | ₹50.35 | ₹1.85 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹173.07 | ₹134.23 | ₹109.21 | ₹7.20 |
| Current Assets | ₹124.05 | ₹115.59 | ₹104.46 | ₹24.40 |
| Total Assets | ₹297.12 | ₹249.82 | ₹213.67 | ₹31.60 |
| Current Liabilities | ₹18.21 | ₹17.02 | ₹13.74 | ₹5.93 |
| Net Current Asset | ₹105.84 | ₹98.57 | ₹90.72 | ₹18.47 |
| Non-Current Liabilities | ₹6.13 | ₹5.02 | ₹3.83 | ₹1.75 |
| Equity Capital | ₹272.79 | ₹227.78 | ₹196.09 | ₹23.93 |
| Total Equity & Liabilities | ₹297.12 | ₹249.82 | ₹213.67 | ₹31.60 |
About 3B BLACKBIO DX LTD.
3B Blackbio DX Limited is an India-based company, which is engaged in the field of polymerase chain reaction (PCR)-based Molecular Diagnostic Kits. Its segments include Agrochemicals and Diagnostic kits. The diagnostics division of the Company is engaged in Design, Development Manufacturing and Commercialization of qPCR tests, Rapid tests, Next Gen Sequencing (NGS)-based Molecular Diagnostic Kits and Extraction Kits for reliable testing on patient samples. Its products include Oncology and Hematology, Antimicrobial Resistance, Infectious Diseases, Human Genetics, Extraction, and Rapid Antigen Kits. The PCR-based Molecular Diagnostic Kits are commercialized with TRUPCR brand to renowned diagnostics labs across the country. The Company also has a Lateral Flow Assays Vertical and a NGS Assay development division. The lateral flow assays are commercialized under the brand name TRURAPID and the NGS assays are commercialized under the brand name TRUNGS.
3B BLACKBIO DX LTD. Financial Highlights
- Revenue: 3B BLACKBIO DX LTD. reported revenue of ₹167.48 crore in FY26 vs ₹111.55 crore in FY25. It showed an increase of 50.14% on a yearly basis.
- Operating Profit: 3B BLACKBIO DX LTD. reported an operating profit of ₹76.97 crore in FY26 vs ₹64.00 crore in FY25. It showed an increase of 20.27% on a year-on-year basis.
- Net Profit: 3B BLACKBIO DX LTD. reported a net profit of ₹59.93 crore in FY26 vs ₹47.69 crore in FY25. It showed an increase of 25.67% on a yearly basis.
3B BLACKBIO DX LTD. Quarterly Result Highlights
- 3B BLACKBIO DX LTD. reported revenue of ₹45.58 crore in Mar 2026, compared with ₹55.94 crore in Dec 2025, representing a decrease of 18.52% on a quarter-on-quarter (QoQ) basis.
- 3B BLACKBIO DX LTD. reported an operating profit of ₹14.65 crore in Mar 2026, compared with ₹26.84 crore in Dec 2025, representing a decrease of 45.42% on a quarter-on-quarter (QoQ) basis.
- 3B BLACKBIO DX LTD. reported a profit of ₹9.80 crore in Mar 2026, compared with ₹22.44 crore in Dec 2025, reflecting a decrease of 56.33% on a QoQ basis.
- The earnings per share (EPS) of 3B BLACKBIO DX LTD. stood at ₹55.66 during Mar 2026.
Similar Stocks
FAQs on 3B BLACKBIO DX LTD. Share Price
What is 3B BLACKBIO DX LTD. share price today?
3B BLACKBIO DX LTD. share price is ₹1,173.50 as on 03 Jul, 2026, 15:59 IST.
How has the 3B BLACKBIO DX LTD. share price performed in the past?
In the last 1 year, 3B BLACKBIO DX LTD. delivered a return of -9.65%. The 3B BLACKBIO DX LTD. share price hit a high of ₹1,441.50 and low of ₹1,085.00.
How much is the Mutual Fund shareholding in 3B BLACKBIO DX LTD. shares?
The Mutual Fund Shareholding in 3B BLACKBIO DX LTD. was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of 3B BLACKBIO DX LTD. shares ?
The 52-week high and low of 3B BLACKBIO DX LTD. share is ₹1,441.50 and ₹1,085.00 as of 03 Jul, 2026.
What is the market cap of 3B BLACKBIO DX LTD.?
The market capitalisation of 3B BLACKBIO DX LTD. is ₹1,036.57 Crores as on 03 Jul, 2026.
What are the stock symbols of 3B BLACKBIO DX LTD.?
The stock symbol of 3B BLACKBIO DX LTD. is 3BBLACKBIO on the NSE, 532067 on the BSE, and the ISIN is INE994E01018.
What was yesterday's closing price of 3B BLACKBIO DX LTD. shares ?
3B BLACKBIO DX LTD. shares closed yesterday at ₹1,205.80 on NSE & ₹1,207.75 on BSE
How to buy 3B BLACKBIO DX LTD. shares?
To buy 3B BLACKBIO DX LTD. shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy 3B BLACKBIO DX LTD. shares on Holidays?
No, shares of 3B BLACKBIO DX LTD. or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell 3B BLACKBIO DX LTD. shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of 3B BLACKBIO DX LTD.?
The PE and PB ratio of 3B BLACKBIO DX LTD. is 17.3 and 3.2 respectively, as on 03 Jul, 2026, 15:59 IST.